Search Results 881-890 of 7558 for 谷歌搜索引擎留痕咨询邮箱：lgooxc@hotmail.com

  1. HTN Management and Cardiovascular Adverse Event Prevention in B-Cell Malignancies Undergoing BTKi - Mayo Clinic

    The purpose of this study is to prospectively define the incidence of new and/or worsening hypertension in patients with B-cell malignancies on Bruton Tyrosine ...

  2. A study of Methylphenidate and Pharmacogenomic Calibration - Mayo Clinic

    About this study. The purpose of this study is to evaluate the predictive value of a custom designed SNP panel test on overall side effect burden caused by ...

  3. Remote Blood Biomarker Monitoring in Frontotemporal Lobar Degeneration - Mayo Clinic

    The purpose of this study is to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) ...

  4. Collaborators - Liver Pathobiology Lab: Gregory J. Gores - Mayo Clinic Research

    Collaborators. Dr. Gores is involved with several research collaborations with other researchers at Mayo. Mayo Clinic collaborators. Mitesh J. Borad, M.D. ...

  5. Evaluation of a Tele-Language Rehabilitation Program - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

    The purpose of this study is to characterize the safety, tolerability, effectiveness, biological activity, and drug/body interactions of IMCgp100, alone and in ...

  7. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

    Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...

  8. Integrative Health and Reasons for Using Complementary Interventions - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Biorepository of Human Blood for Age Related Research - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...